Purchases and Sales Made in Q1 2025 in Nautilus Biotechnology, Inc. (NAUT)
This table provides information about the institutional ownership of Nautilus Biotechnology, Inc. (NAUT) during Q1 2025. The information is specifically focused on institutions that hold shares of Nautilus Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Barclays PLC
London, X0 |
SELL
|
- |
-24.2K- 19.36% |
$20.8K - $49.4K
|
101K
$80.8K
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
SELL
|
- |
-25.5K- 53.91% |
$21.9K - $51.9K
|
21.8K
$17.4K
|
|
|
May 14, 2025
Q1 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-36.7K- 33.8% |
$31.6K - $74.8K
|
71.9K
$57.5K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-81.1K- 55.57% |
$69.7K - $165K
|
64.8K
$51.9K
|
|
|
May 13, 2025
Q1 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-110K- 14.34% |
$95K - $225K
|
660K
$528K
|
|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-117K- 53.26% |
$101K - $239K
|
103K
$82.3K
|
|
|
May 15, 2025
Q1 2025
|
Wexford Capital LP
Greenwich, CT |
SELL
|
- |
-221K- 67.85% |
$190K - $450K
|
105K
$83.7K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-221K- 56.26% |
$190K - $452K
|
172K
$138K
|
|
|
May 15, 2025
Q1 2025
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-687K- 39.03% |
$590K - $1.4M
|
1.07M
$858K
|